Get started
Author

Estefania Traver

Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial
2023 · Wolfgang Köhler, Marc Engelen, et al. · The Lancet Neurology · 49
PDF
The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy
2021 · Laura Rodríguez-Pascau, Anna Vilalta, et al. · Science Translational Medicine · 42
Mucosal mast cells mediate motor response induced by chronic oral exposure to ovalbumin in the rat gastrointestinal tract
2009 · E. Traver, R. Torres, et al. · Neurogastroenterology & Motility · 24
Liver impairment after portacaval shunt in the rat: The loss of protective role of mast cells?
2011 · Maria-Angeles Aller, Vicente Martinez, et al. · Acta Histochemica · 7
Clinical pharmacokinetics of leriglitazone and a translational approach using PBPK modeling to guide the selection of the starting dose in children
2024 · Estefania Traver, Laura Rodríguez‐Pascau, et al. · CPT Pharmacometrics & Systems Pharmacology · 3
PDF
The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy
2022 · Rodriguez-Pascau L, Vilalta A, et al. · Yearbook of pediatric endocrinology
248 NGF is Implicated in the Hypercontractile Responses of the Colon in a Model of Ovalbumin-Induced Gut Dysfunction in Rats
2010 · Ferran Jardi, Vicente Martinez, et al. · Gastroenterology
PDF
Works count: 7
Citation count: 125
H-index: 4
I10-index: 3
Year
Topic
Type